Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled
Junlong Guo,1,2 Lulu Yang,1,2 Yan Xu,1,2 Chenxi Zhang,1,2 Xian Luo,1,2 Shuai Liu,1– 3 Lihua Yao,4 Hanping Bai,4 Xiaofen Zong,4 Jihui Zhang,5 Zhongchun Liu,4 Bin Zhang1,2 1Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of Chin...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/194172ebcb8144f9bd5ed5a960be73d4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:194172ebcb8144f9bd5ed5a960be73d4 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:194172ebcb8144f9bd5ed5a960be73d42021-12-02T18:20:42ZPrevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled1179-1608https://doaj.org/article/194172ebcb8144f9bd5ed5a960be73d42021-06-01T00:00:00Zhttps://www.dovepress.com/prevalence-and-risk-factors-associated-with-insomnia-symptoms-among-th-peer-reviewed-fulltext-article-NSShttps://doaj.org/toc/1179-1608Junlong Guo,1,2 Lulu Yang,1,2 Yan Xu,1,2 Chenxi Zhang,1,2 Xian Luo,1,2 Shuai Liu,1– 3 Lihua Yao,4 Hanping Bai,4 Xiaofen Zong,4 Jihui Zhang,5 Zhongchun Liu,4 Bin Zhang1,2 1Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Guangdong Mental Health Center, Guangdong Provincial People’s Hospital, Guangzhou, People’s Republic of China; 3Department of Psychiatry, The Third People’s Hospital of Qinghai Province, Xining, People’s Republic of China; 4Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 5Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Bin ZhangDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, People’s Republic of ChinaTel +86-20-62786731Email zhang73bin@hotmail.comZhongchun LiuDepartment of Psychiatry, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, People’s Republic of ChinaEmail zcliu6@whu.edu.cnIntroduction: The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had been initially control.Methods: An online survey was conducted among Chinese citizens through the JD Health APP. The questionnaire was used for collecting demographic data and self-designed questions related to the COVID-19 outbreak. Insomnia Severity Index, Patient Health Questionnaire-9, Somatic Symptom Scale-8 and Impact of Events Scale-Revised were used for measuring psychological symptoms. To examine the associations of sociodemographic and psychological factors with insomnia symptoms, a binary logistic regression was used.Results: In total, there were 14,894 eligible participants, and 4601 (30.9%) participants were found to have insomnia symptoms. The regression model revealed that a higher risk of insomnia symptoms was associated with being over the age of 40 years, having history of psychiatric disorders, smoking, having infected friends or colleagues, having depressive or somatic symptoms, experiencing psychological distress and feeling estranged from family members. Meanwhile a lower risk of insomnia symptoms was associated with being female, having closer family relationships, not feeling alienated from others and being satisfied with the available information.Conclusion: In our study, 30.9% of the participants in the general public reported insomnia symptoms after the COVID-19 epidemic had been initially controlled. When providing precise interventions for insomnia, extra attention should be paid to the individuals who are male, elderly and smokers, and those with psychiatric disorder history, with infected friends or colleagues, with psychological symptoms and with poor social support.Keywords: insomnia symptoms, prevalence, COVID-19, under control, general public, ChinaGuo JYang LXu YZhang CLuo XLiu SYao LBai HZong XZhang JLiu ZZhang BDove Medical Pressarticleinsomnia symptomsprevalencecovid-19under controlgeneral publicchinaPsychiatryRC435-571Neurophysiology and neuropsychologyQP351-495ENNature and Science of Sleep, Vol Volume 13, Pp 703-712 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
insomnia symptoms prevalence covid-19 under control general public china Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495 |
| spellingShingle |
insomnia symptoms prevalence covid-19 under control general public china Psychiatry RC435-571 Neurophysiology and neuropsychology QP351-495 Guo J Yang L Xu Y Zhang C Luo X Liu S Yao L Bai H Zong X Zhang J Liu Z Zhang B Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| description |
Junlong Guo,1,2 Lulu Yang,1,2 Yan Xu,1,2 Chenxi Zhang,1,2 Xian Luo,1,2 Shuai Liu,1– 3 Lihua Yao,4 Hanping Bai,4 Xiaofen Zong,4 Jihui Zhang,5 Zhongchun Liu,4 Bin Zhang1,2 1Department of Psychiatry, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Guangdong Mental Health Center, Guangdong Provincial People’s Hospital, Guangzhou, People’s Republic of China; 3Department of Psychiatry, The Third People’s Hospital of Qinghai Province, Xining, People’s Republic of China; 4Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, People’s Republic of China; 5Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Southern Medical University, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Bin ZhangDepartment of Psychiatry, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, 510515, People’s Republic of ChinaTel +86-20-62786731Email zhang73bin@hotmail.comZhongchun LiuDepartment of Psychiatry, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, 430060, People’s Republic of ChinaEmail zcliu6@whu.edu.cnIntroduction: The prevalence rate and related factors of insomnia remained unknown after the COVID-19 epidemic had been under control. Therefore, we conducted this survey to investigate the prevalence rate and related factors of insomnia symptoms in the Chinese general public after the COVID-19 had been initially control.Methods: An online survey was conducted among Chinese citizens through the JD Health APP. The questionnaire was used for collecting demographic data and self-designed questions related to the COVID-19 outbreak. Insomnia Severity Index, Patient Health Questionnaire-9, Somatic Symptom Scale-8 and Impact of Events Scale-Revised were used for measuring psychological symptoms. To examine the associations of sociodemographic and psychological factors with insomnia symptoms, a binary logistic regression was used.Results: In total, there were 14,894 eligible participants, and 4601 (30.9%) participants were found to have insomnia symptoms. The regression model revealed that a higher risk of insomnia symptoms was associated with being over the age of 40 years, having history of psychiatric disorders, smoking, having infected friends or colleagues, having depressive or somatic symptoms, experiencing psychological distress and feeling estranged from family members. Meanwhile a lower risk of insomnia symptoms was associated with being female, having closer family relationships, not feeling alienated from others and being satisfied with the available information.Conclusion: In our study, 30.9% of the participants in the general public reported insomnia symptoms after the COVID-19 epidemic had been initially controlled. When providing precise interventions for insomnia, extra attention should be paid to the individuals who are male, elderly and smokers, and those with psychiatric disorder history, with infected friends or colleagues, with psychological symptoms and with poor social support.Keywords: insomnia symptoms, prevalence, COVID-19, under control, general public, China |
| format |
article |
| author |
Guo J Yang L Xu Y Zhang C Luo X Liu S Yao L Bai H Zong X Zhang J Liu Z Zhang B |
| author_facet |
Guo J Yang L Xu Y Zhang C Luo X Liu S Yao L Bai H Zong X Zhang J Liu Z Zhang B |
| author_sort |
Guo J |
| title |
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| title_short |
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| title_full |
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| title_fullStr |
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| title_full_unstemmed |
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially Controlled |
| title_sort |
prevalence and risk factors associated with insomnia symptoms among the chinese general public after the coronavirus disease 2019 epidemic was initially controlled |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/194172ebcb8144f9bd5ed5a960be73d4 |
| work_keys_str_mv |
AT guoj prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT yangl prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT xuy prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT zhangc prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT luox prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT lius prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT yaol prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT baih prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT zongx prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT zhangj prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT liuz prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled AT zhangb prevalenceandriskfactorsassociatedwithinsomniasymptomsamongthechinesegeneralpublicafterthecoronavirusdisease2019epidemicwasinitiallycontrolled |
| _version_ |
1718378139592163328 |